The Stanford University Department of Surgery has announced that Dr. Electron Kebebew will be the next chief of general surgery effective March 1, 2018. (Courtesy photo)
Tadias Magazine
By Tadias Staff
January 13th, 2018
New York (TADIAS) — This coming Spring Ethiopian American Dr. Electron Kebebew will assume his new post as Chief of General Surgery at Stanford University’s Department of Surgery in Palo Alto, California.
Stanford is one of the top universities in America and one of the world’s leading teaching and research institutions.
In a statement the Chair of the University’s Department of Surgery Dr. Mary Hawn said: “I’m thrilled to have Dr. Kebebew join Stanford Surgery in this important leadership role as chief of general surgery. Dr. Kebebew is an internationally-renowned endocrine surgeon whose research has changed the way we treat patients with endocrine cancers. He is the consummate surgeon, scientist and leader and will bring our program to new heights.”
The press release notes that “Kebebew received his Bachelor’s degree from the University of California, Los Angeles, in chemical engineering. He completed his medical training, surgical residency and NCI T32 surgical oncology basic science fellowship at the University of California, San Francisco (UCSF). Since 2012, he has served as inaugural chief of newly-established endocrine oncology branch at the National Cancer Institute.”
“This is a great opportunity to be part of a dynamic surgical department,” said Kebebew. “I am excited to make Stanford’s division a world leader in general surgery subspecialty care and research that impacts patient care.”
According to Stanford: “Kebebew has published more than 300 articles, chapters and textbooks and has received awards from the American Cancer Society, American Association for Cancer Research, American Thyroid Association, American Association of Endocrine Surgeons, and International Association of Endocrine Surgeons. His current research focuses on the genetic/genomic changes associated with endocrine cancers with the ultimate goal of identifying therapeutic targets and novel anticancer agents for endocrine cancers, and diagnostic and prognostic markers for endocrine tumors.”
Kebebew succeeds Dr. Jeffrey Norton, who has led the Division of General Surgery since 2006.
“Dr. Kebebew is perfect fit for this position because of his prior experience as leader of a very successful branch at the [National Cancer Institute], his record of cutting-edge research in endocrine oncology and his plan for programmatic development in endocrine oncology in the Cancer Center here at Stanford,” said Norton. “He is an extremely bright, accomplished surgeon and a true leader in surgery.”
—
Join the conversation on Twitter and Facebook.
